Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.
Venken T, Miller IS, Arijs I, Thomas V, Barat A, Betge J, Zhan T, Gaiser T, Ebert MP, O'Farrell AC, Prehn J, Klinger R, O'Connor DP, Moulton B, Murphy V, Serna G, Nuciforo PG, McDermott R, Bird B, Leonard G, Grogan L, Horgan A, Schulte N, Moehler M, Lambrechts D, Byrne AT.
Venken T, et al. Among authors: schulte n.
NPJ Genom Med. 2024 May 29;9(1):33. doi: 10.1038/s41525-024-00415-x.
NPJ Genom Med. 2024.
PMID: 38811554
Free PMC article.